Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Julphar
McKinsey
Teva
Covington
UBS
Express Scripts
Cantor Fitzgerald
Mallinckrodt
Chubb

Generated: January 17, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,771,041

« Back to Dashboard

Summary for Patent: 4,771,041
Title: Method for combating virus infection
Abstract:A method for the selective treatment of virus infections in animals and man comprising administering to a host so infected a therapeutically effective amount of phosphonoformic acid or a physiologically acceptable salt thereof.
Inventor(s): Eriksson; Bertil F. H. (Tumba, SE), Helgstrand; Ake J. E. (Lund, SE), Misiorny, deceased; Alfons (late of Bandhagen, SE), Misiorny, legal representive; Karl H. (Sodertalje, SE), Stening; Goran B. (Sodertalje, SE), Stridh; Stig-Ake A. (Sodertalje, SE)
Assignee: Astra Lakemedel Aktiebolag (SE)
Application Number:06/793,575
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form;

Drugs Protected by US Patent 4,771,041

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 4,771,041

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Sweden7607496Jul 1, 1976

International Patents Family Members for US Patent 4,771,041

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria A465477 ➤ Subscribe
Austria 369014 ➤ Subscribe
Australia 510809 ➤ Subscribe
Australia 2650577 ➤ Subscribe
Belgium 856355 ➤ Subscribe
Bulgaria 60834 ➤ Subscribe
Canada 1077848 ➤ Subscribe
Switzerland 641471 ➤ Subscribe
Germany 2728685 ➤ Subscribe
Denmark 288877 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Argus Health
Medtronic
Federal Trade Commission
Julphar
McKinsey
Covington
Moodys
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot